Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Psychiatry

• Publication date

  2003-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/APPI.AJP.160.12.2231PMID 14638596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.

  2002cited by this paper
• The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

  2001cited by this paper
• Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.

  2001cited by this paper
• Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study.

  2001cited by this paper
• Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy.

  2000cited by this paper
• Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0 Tesla

  2000influential reference
• Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia.

  2000cited by this paper
• In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics.

  1999cited by this paper
• Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia

  1997cited by this paper
• Clinical Child Neuropsychiatry

  1996cited by this paper
• Glutamate receptor dysfunction and schizophrenia.

  1995cited by this paper
• The use of a priori knowledge to quantify short echo in vivo 1h mr spectra

  1995cited by this paper
• Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

  1990cited by this paper

• Elevated glutamine but not glutamate is associated with clozapine eligibility in an early psychosis sample

  2026cites this paper
• Subcortical volume alteration and correlation with social function under chlorpromazine versus clozapine treatment in schizophrenia

  2025influential citation
• Hippocampal subfield activity in schizophrenia: Effects of the disease course.

  2025cites this paper
• Simultaneous in vivo detection of spectrally resolved glutamate, glutamine, and glutathione at 3 T with NAA‐aspartyl editing and echo‐time optimization

  2025cites this paper
• Aging in Schizophrenia: Perspectives on Molecular Mechanisms and a Mini-review.

  2025cites this paper
• Enhanced detection of glutamate via transverse relaxation encoding with narrowband decoupling in the human brain

  2025cites this paper
• Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders

  2024cites this paper
• The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders

  2024cites this paper
• Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis

  2023cites this paper
• Neuroimaging Brain Inflammation in Mood Disorders

  2021cites this paper
• Molecular Imaging of Dopamine and Antipsychotics in Bipolar Disorder

  2021cites this paper
• Brain Imaging of Reward Dysfunction in Unipolar and Bipolar Disorders

  2021cites this paper
• Determinants of Schizophrenia Endophenotypes Based on Neuroimaging and Biochemical Parameters

  2021cites this paper
• Neuroanatomical Findings in Bipolar Disorder

  2021cites this paper
• Magnetoencephalography Studies in Mood Disorders

  2021cites this paper
• Functional Near-Infrared Spectroscopy Studies in Mood Disorders

  2021cites this paper
• Metabolite Alterations in Adults With Schizophrenia, First Degree Relatives, and Healthy Controls: A Multi-Region 7T MRS Study

  2021cites this paper
• Effects of Lithium on Brain Structure in Bipolar Disorder

  2021cites this paper
• Brain Imaging and the Mechanisms of Antidepressant Action

  2021cites this paper
• Neuroimaging Biomarkers in Pediatric Mood Disorders

  2021cites this paper
• Brain Imaging Methods in Mood Disorders

  2021cites this paper
• Resting-State Functional Connectivity in Unipolar Depression

  2021cites this paper
• Magnetic Resonance Spectroscopy Investigations of Bioenergy and Mitochondrial Function in Mood Disorders

  2021cites this paper
• Glutamate & Empathy

  2021cites this paper
• Neuroanatomical Findings in Unipolar Depression and the Role of the Hippocampus

  2021cites this paper
• Medial Prefrontal Cortex Glutamate is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of 1H-MRS Studies

  2021cites this paper
• Imaging Glutamatergic and GABAergic Abnormalities in Mood Disorders

  2021cites this paper
• fMRI Neurofeedback as Treatment for Depression

  2021cites this paper
• Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level

  2021cites this paper
• Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

  2021cites this paper
• The Etiology of Auditory Hallucinations in Schizophrenia: From Multidimensional Levels

  2021cites this paper
• Frontal neural metabolite changes in schizophrenia and their association with cognitive control: A systematic review

  2021cites this paper
• Imaging Genetic and Epigenetic Markers in Mood Disorders

  2021cites this paper
• An Overview of Machine Learning Applications in Mood Disorders

  2021cites this paper
• Functional Connectome in Bipolar Disorder

  2021cites this paper
• Therapeutic potentiality of a new flavonoid against ketamine induced glutamatergic dysregulation in schizophrenia: In vivo and in silico approach.

  2021cites this paper
• Neuroimaging Studies of Effects of Psychotherapy in Depression

  2021cites this paper
• Electrophysiological Biomarkers for Mood Disorders

  2021cites this paper
• The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders

  2020cites this paper
• Editorial: Back to the Future: On the Road Towards Precision Psychiatry

  2020cites this paper
• Are working memory and glutamate concentrations involved in early‐life stress and severity of psychosis?

  2020cites this paper
• ALDH4A1 expression levels are elevated in postmortem brains of patients with schizophrenia and are associated with genetic variants in enzymes related to proline metabolism.

  2020cites this paper
• Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?

  2020cites this paper
• Rostral Anterior Cingulate Glutamine/Glutamate Disbalance in Major Depressive Disorder Depends on Symptom Severity.

  2019cites this paper
• Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis

  2019cites this paper
• Early Treatment Response in First Episode Psychosis: A 7-Tesla Magnetic Resonance Spectroscopic Study of Glutathione and Glutamate

  2019cites this paper
• 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia

  2019cites this paper
• Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.

  2019cites this paper
• Investigation into effects of chronic treatment with antipsychotics using a combination of behavioural and electrophysiological techniques

  2019cites this paper
• Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway.

  2019cites this paper
• Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.

  2019cites this paper
• Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study

  2018cites this paper
• Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia

  2018influential citation
• Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.

  2018cites this paper
• A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia

  2018cites this paper
• Putative Astroglial Dysfunction in Schizophrenia: A Meta-Analysis of 1H-MRS Studies of Medial Prefrontal Myo-Inositol

  2018cites this paper
• Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T

  2017cites this paper
• MK‐801 reduces sensitivity to Müller‐Lyer's illusion in capuchin monkeys

  2017cites this paper
• In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.

  2017cites this paper
• Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T.

  2017cites this paper
• Glutamate/GABA+ ratio is associated with the psychosocial domain of autistic and schizotypal traits

  2017cites this paper
• A review of altered biochemistry in the anterior cingulate cortex of first-episode psychosis

  2017cites this paper
• Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study

  2017cites this paper
• 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.

  2017cites this paper
• Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum

  2017cites this paper
• Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.

  2016cites this paper
• Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders.

  2016cites this paper
• Title: Evaluation of Neuron-glia Integrity by in vivo Proton Magnetic Resonance Spectroscopy: Implications for Psychiatric Disorders

  2016cites this paper
• Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4Tesla (1)H-MRS study.

  2016cites this paper
• Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.

  2016cites this paper
• Different dosing regimens of repeated ketamine administration have opposite effects on novelty processing in rats.

  2016cites this paper
• Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study

  2016cites this paper
• A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.

  2016influential citation
• Measuring Brain Serine With Proton Magnetic Resonance Spectroscopy At 3.0 Tesla

  2016cites this paper
• Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction

  2016cites this paper
• Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders

  2016cites this paper
• The use of adjuvant L-arginine in schizophrenia: A behavioural and neurochemical analysis

  2016cites this paper
• T proton magnetic resonance spectroscopy of GABA , glutamate , and glutamine reveals altered concentrations in schizophrenia patients and healthy siblingsGABA and glutamate in schizophrenia patients and siblings

  2016cites this paper
• Regional distributions of brain glutamate and glutamine in normal subjects

  2016cites this paper
• Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.

  2016cites this paper
• Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.

  2016cites this paper
• Metabotropic glutamate receptor mGluR 2 / 3 and mGluR 5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression , bipolar disorder and schizophrenia : implications for novel mGluR-based therapeutics

  2016influential citation
• Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

  2015cites this paper
• Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation.

  2015cites this paper
• Behavioural and pharmacological characterization of a mouse model for psychotic disorders focus on glutamatergic transmission

  2015cites this paper
• Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls

  2015cites this paper
• Detection of glutamate, glutamine, and glutathione by radiofrequency suppression and echo time optimization at 7 tesla

  2015cites this paper
• Sleep spindles are related to schizotypal personality traits and thalamic glutamine/glutamate in healthy subjects.

  2015cites this paper
• In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.

  2015cites this paper
• Glutamate and dopamine in schizophrenia: An update for the 21st century

  2015cites this paper
• Effect of l-theanine on glutamatergic function in patients with schizophrenia

  2015cites this paper
• Auditory hallucinations: A review of the ERC "VOICE" project.

  2015cites this paper
• Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy

  2015cites this paper
• Chapter 39 – Schizophrenia

  2015cites this paper
• Imaging the effects of ketamine use and abuse in the brain

  2015cites this paper
• Resting and Functional Magnetic Resonance Spectroscopy of Glutamate in Schizophrenia at 7 Tesla

  2015cites this paper
• Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.

  2015cites this paper
• Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813

  2015cites this paper
• In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.

  2015cites this paper
• 1 Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia – A Systematic Review and Meta-Analysis

  2015cites this paper